---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-016702"
form_type: "8-K"
ticker: "DMAA"
cik: "0002028614"
company_name: "Drugs Made In America Acquisition Corp."
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T05:05:12.923874+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# SPAC raises $30M via over-allotment; trust now $231.15M

## Summary
- Underwriters exercised over-allotment option in full on Feb 18, 2025; 3M additional units at $10/unit raised $30M.
- Sponsor purchased 30K additional private placement units for $300K, bringing total private units to 430K.
- Total trust account now holds $231.15M from IPO, over-allotment, and private placement proceeds.
- 1,285,714 founder shares are no longer subject to forfeiture due to over-allotment exercise.
- Underwriters received 30K representative shares issued in connection with the over-allotment.

## SEC filing metadata
- accession: 0001213900-25-016702
- form_type: 8-K
- ticker: DMAA
- cik: 0002028614
- company_name: Drugs Made In America Acquisition Corp.
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/0001213900-25-016702-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/ea0231936-8k_drugs.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-016702
- JSON: https://secwatch.observer/filing/0001213900-25-016702.json
- Plain text: https://secwatch.observer/filing/0001213900-25-016702.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.